BattifloraH.The biology of the keratins and their diagnostic applications. In: De LellisR.A., ed. Advances in immunohistochemistry.New York: Raven Press, 1988; 191–221.
2.
GionM., MioneR., GattiC.Tissue polypeptide antigen in breast cancer cytosol. A new effective prognostic indicator.Eur J Cancer1993; 29A(1): 66–9.
3.
BodenmüllerH., BanauchD., OfenlochB., JaworekD., DessauerA.Technical evaluation of a new automated tumor marker assay in the enzymun-test CYFRA 21–1. In: KlapdorR., ed. Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the nineties. Cancer of the breast - State and trends in diagnosis and therapy. München: Zuckschwerdt Verlag, 1992; 137–8.
4.
PujolJ.L., GrenierJ., DaurésJ.P., DaverA., PujolH., MichaelF.B.Serum fragment of cytokeratin subunit 19 measured by CYFRA 21–1 immunoradiometric assay as a marker of lung cancer.Cancer Res1993; 53: 61–66.
5.
StieberP., HasholznerU., BodenmüllerH.CYFRA 21–1 – A new marker in lung cancer.Cancer1993; 72: 707–13.
6.
HasholznerU., StieberP., FiebigM., Sunder-PlassmannL., Fateh-MoghadamA.A new tumor marker for non-small cell lung cancer (NSCLC). In: KlapdorR., ed. Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the nineties. Cancer of the breast - State and trends in diagnosis and therapy. München: Zuckschwerdt Verlag, 1992; 134–6.
7.
DittadiR., GionM., PaganV.Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.Br J Cancer1991; 64: 741–4.